Application 020818
- Type
- NDA
- Sponsor
- NOVARTIS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 12.5MG;80MG | Yes | No |
| 002 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 12.5MG;160MG | Yes | No |
| 003 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 25MG;160MG | Yes | No |
| 004 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 12.5MG;320MG | Yes | No |
| 005 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | TABLET;ORAL | 25MG;320MG | Yes | Yes |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020818-001 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 1998-03-06 |
| N020818-002 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;160MG | TABLET / ORAL | AB | RLD | 1998-03-06 |
| N020818-003 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;160MG | TABLET / ORAL | AB | RLD | 2002-01-17 |
| N020818-004 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 12.5MG;320MG | TABLET / ORAL | AB | RLD | 2006-04-28 |
| N020818-005 | DIOVAN HCT | HYDROCHLOROTHIAZIDE; VALSARTAN | 25MG;320MG | TABLET / ORAL | AB | RLD, RS | 2006-04-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| N020818-001 | AB |
| N020818-002 | AB |
| N020818-003 | AB |
| N020818-004 | AB |
| N020818-005 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020818-001 | DIOVAN HCT | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020818-002 | DIOVAN HCT | 12.5MG;160MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020818-003 | DIOVAN HCT | 25MG;160MG | TABLET / ORAL | AB | RLD | 2002-01-17 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020818-004 | DIOVAN HCT | 12.5MG;320MG | TABLET / ORAL | AB | RLD | 2006-04-28 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020818-005 | DIOVAN HCT | 25MG;320MG | TABLET / ORAL | AB | RLD, RS | 2006-04-28 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-001 | DIOVAN HCT | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-002 | DIOVAN HCT | 12.5MG;160MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-003 | DIOVAN HCT | 25MG;160MG | TABLET / ORAL | AB | RLD | 2002-01-17 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-004 | DIOVAN HCT | 12.5MG;320MG | TABLET / ORAL | AB | RLD | 2006-04-28 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-005 | DIOVAN HCT | 25MG;320MG | TABLET / ORAL | AB | RLD, RS | 2006-04-28 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-001 | DIOVAN HCT | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-002 | DIOVAN HCT | 12.5MG;160MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-003 | DIOVAN HCT | 25MG;160MG | TABLET / ORAL | AB | RLD | 2002-01-17 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-004 | DIOVAN HCT | 12.5MG;320MG | TABLET / ORAL | AB | RLD | 2006-04-28 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-005 | DIOVAN HCT | 25MG;320MG | TABLET / ORAL | AB | RLD, RS | 2006-04-28 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-001 | DIOVAN HCT | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 1998-03-06 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-002 | DIOVAN HCT | 12.5MG;160MG | TABLET / ORAL | AB | RLD | 1998-03-06 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-003 | DIOVAN HCT | 25MG;160MG | TABLET / ORAL | AB | RLD | 2002-01-17 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-004 | DIOVAN HCT | 12.5MG;320MG | TABLET / ORAL | AB | RLD | 2006-04-28 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-005 | DIOVAN HCT | 25MG;320MG | TABLET / ORAL | AB | RLD, RS | 2006-04-28 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-001 | DIOVAN HCT | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 1998-03-06 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-002 | DIOVAN HCT | 12.5MG;160MG | TABLET / ORAL | AB | RLD | 1998-03-06 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-003 | DIOVAN HCT | 25MG;160MG | TABLET / ORAL | AB | RLD | 2002-01-17 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-004 | DIOVAN HCT | 12.5MG;320MG | TABLET / ORAL | AB | RLD | 2006-04-28 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-005 | DIOVAN HCT | 25MG;320MG | TABLET / ORAL | AB | RLD, RS | 2006-04-28 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-001 | DIOVAN HCT | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-002 | DIOVAN HCT | 12.5MG;160MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-003 | DIOVAN HCT | 25MG;160MG | TABLET / ORAL | AB | RLD | 2002-01-17 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-004 | DIOVAN HCT | 12.5MG;320MG | TABLET / ORAL | AB | RLD | 2006-04-28 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-005 | DIOVAN HCT | 25MG;320MG | TABLET / ORAL | AB | RLD, RS | 2006-04-28 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-001 | DIOVAN HCT | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-002 | DIOVAN HCT | 12.5MG;160MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-003 | DIOVAN HCT | 25MG;160MG | TABLET / ORAL | AB | RLD | 2002-01-17 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-004 | DIOVAN HCT | 12.5MG;320MG | TABLET / ORAL | AB | RLD | 2006-04-28 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-005 | DIOVAN HCT | 25MG;320MG | TABLET / ORAL | AB | RLD, RS | 2006-04-28 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-001 | DIOVAN HCT | 12.5MG;80MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-002 | DIOVAN HCT | 12.5MG;160MG | TABLET / ORAL | AB | RLD | 1998-03-06 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-003 | DIOVAN HCT | 25MG;160MG | TABLET / ORAL | AB | RLD | 2002-01-17 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-004 | DIOVAN HCT | 12.5MG;320MG | TABLET / ORAL | AB | RLD | 2006-04-28 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-005 | DIOVAN HCT | 25MG;320MG | TABLET / ORAL | AB | RLD, RS | 2006-04-28 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | N020818-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020818-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020818-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020818-004 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | N020818-005 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-004 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | N020818-005 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-004 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | N020818-005 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-004 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | N020818-005 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-004 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | N020818-005 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-004 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | N020818-005 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-004 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | N020818-005 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-004 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | N020818-005 | AB | 1 | 5bbf6a4d5a75… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Diovan HCT | VALSARTAN AND HYDROCHLOROTHIAZIDE | Novartis Pharmaceuticals Corporation | d76a0419-05ee-437e-884c-65807aea9569 | 2026-02-13 | Boxed warning, Warnings, Adverse reactions | 020818 NDA020818 0078-0314 0078-0471 0078-0315 0078-0383 0078-0472 |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0314 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0315 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0383 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0471 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0078-0472 | Diovan HCT | valsartan and hydrochlorothiazide | Novartis Pharmaceuticals Corporation | NDA | Current |
| 0781-5948 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-5949 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-5950 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-5951 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 0781-5952 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | Sandoz Inc | NDA AUTHORIZED GENERIC | Current |
| 55289-820 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-820 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-820 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-820 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-820 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-820 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-820 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-838 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-838 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-838 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-838 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-838 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-838 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-838 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 55289-838 | Diovan HCT | valsartan and hydrochlorothiazide | PD-Rx Pharmaceuticals, Inc. | NDA | Current |
| 68258-6053 | Diovan HCT | valsartan and hydrochlorothiazide | Dispensing Solutions, Inc. | NDA | Current |
| 68258-6056 | Diovan HCT | valsartan and hydrochlorothiazide | Dispensing Solutions, Inc. | NDA | Current |
| 68258-6095 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | Dispensing Solutions, Inc. | NDA AUTHORIZED GENERIC | Current |
| 68258-6096 | Valsartan and Hydrochlorothiazide | valsartan and hydrochlorothiazide | Dispensing Solutions, Inc. | NDA AUTHORIZED GENERIC | Current |
| 68258-6972 | Diovan HCT | valsartan and hydrochlorothiazide | Dispensing Solutions, Inc. | NDA | Current |
| 68258-6973 | Diovan HCT | valsartan and hydrochlorothiazide | Dispensing Solutions, Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 64430 | SUPPL | 2020-08-27 |
| 64383 | SUPPL | 2020-08-24 |
| 59062 | SUPPL | 2019-06-13 |
| 59057 | SUPPL | 2019-06-13 |
| 35409 | SUPPL | 2015-07-30 |
| 35408 | SUPPL | 2014-09-26 |
| 25908 | SUPPL | 2014-09-26 |
| 13479 | SUPPL | 2014-06-03 |
| 3411 | SUPPL | 2014-06-03 |
| 35407 | SUPPL | 2014-03-19 |
| 25907 | SUPPL | 2014-03-19 |
| 13480 | SUPPL | 2014-03-19 |
| 3412 | SUPPL | 2014-03-19 |
| 25906 | SUPPL | 2012-10-09 |
| 35406 | SUPPL | 2012-10-05 |
| 35405 | SUPPL | 2012-07-30 |
| 25905 | SUPPL | 2012-07-30 |
| 25903 | SUPPL | 2012-02-17 |
| 13477 | SUPPL | 2012-02-17 |
| 25904 | SUPPL | 2012-01-23 |
| 13478 | SUPPL | 2012-01-23 |
| 23600 | ORIG | 2011-12-22 |
| 25902 | SUPPL | 2011-12-14 |
| 25900 | SUPPL | 2011-12-14 |
| 35404 | SUPPL | 2011-12-12 |
| 35402 | SUPPL | 2011-12-12 |
| 35403 | SUPPL | 2011-06-27 |
| 25901 | SUPPL | 2011-06-09 |
| 13476 | SUPPL | 2010-05-03 |
| 3410 | SUPPL | 2010-04-23 |
| 25899 | SUPPL | 2008-08-05 |
| 25898 | SUPPL | 2007-09-11 |
| 25897 | SUPPL | 2006-12-04 |
| 13475 | SUPPL | 2006-11-22 |
| 25896 | SUPPL | 2006-05-02 |
| 13474 | SUPPL | 2006-05-02 |
| 35401 | SUPPL | 2005-07-15 |
| 25895 | SUPPL | 2005-07-15 |
| 43564 | SUPPL | 2005-07-08 |
| 25894 | SUPPL | 2004-06-02 |
| 13473 | ORIG | 2004-06-02 |
| 3409 | ORIG | 2004-06-02 |
| 41720 | ORIG | 2003-08-08 |
| 41721 | SUPPL | 2003-07-08 |
| 25893 | SUPPL | 2002-01-17 |